Vor Biopharma
Brikena Gjeci has worked as an Associate Scientist II at Vor Biopharma since March 2021. Prior to that, they were a Research Associate at FogPharma from March 2020 to March 2021.
Brikena Gjeci's education history includes a Bachelor's degree in Biology/Biological Sciences, General from Bridgewater State University, which they obtained between 2013 and 2017. Following this, they pursued a Master's degree in Molecular Biology at Tufts University from 2018 to 2020.
This person is not in the org chart
Vor Biopharma
3 followers
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer. It is focused on developing technologies that can enable selective targeting of cancer cells without impacting normal cells.